CellPort Software at Advanced Therapies Europe 2025

CellPort Software will be in Barcelona for Advanced Therapies Europe 2025 (September 2–4) bringing together leaders advancing cell and gene therapy. With EMA’s 2025 ATMP guidance elevating expectations for traceability, documentation integrity, and validated records, CellPort’s all-in-one lab management system helps operationalize those requirements—strengthening lineage oversight, reducing variability, and keeping data inspection-ready.

‍

CellPort on Stage

Panel: Is decentralised manufacturing the way to cost effectiveness?
Speaker: Patrick Dentinger, CEO, CellPort
Timing: Wednesday, September 3 at 11:00 AM, Theatre 2

‍

Meet With CellPort

Schedule a meeting with our team to learn how CellPort can support your operations.

• Bi‑directional cell lineage tracking that ensures visibility from source through intermediates to final batches
• Real‑time traceability for reagents, raw materials, and equipment usage
• GMP‑aligned, validated digital batch records, fit for Annex 11, 21 CFR Part 11, and data‑integrity expectations
• Standardized digital protocols and master batch records to reduce risk and support audit readiness

‍

We look forward to connecting with you!